Skip to content

BridgeBio Oncology Therapeutics, Inc.: filings

Every BridgeBio Oncology Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 10 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 2026381100001193125-26-344661
10-Q2026-05-12fiscal Q1 202637760001193125-26-219829
10-K2026-03-05fiscal FY 202541820001193125-26-094112
10-Q2025-11-12fiscal Q3 2025381120001193125-25-277834
10-Q2025-08-01fiscal Q2 202517480001213900-25-070659
10-Q2025-05-15fiscal Q1 202517340001213900-25-044424
10-K2025-03-11fiscal FY 202418280001213900-25-022387
10-Q2024-11-14fiscal Q3 202418370001213900-24-098483
10-Q2024-08-14fiscal Q2 202417330001213900-24-068630
10-Q2024-05-15fiscal Q1 202417250001213900-24-043582

Inspect the source

Entity
BridgeBio Oncology Therapeutics, Inc. / CIK 0001869105
Captured
2026-09-21T17:32:21.752Z
SEC response SHA-256
e3a8b48657e906e1340ff05c8830da3e6448920aea4584fce37891a67c96d2e7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001869105.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))